SPLITOAK STRATEGIES LLC for CARIS LIFE SCIENCES, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare coverage and reimbursement of Next Generation Sequencing in advanced cancer. Finalize PAMA reform of clinical lab reimbursement.
Foreign entity interest: Ownership and therefore indirect interest in issue
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE | Legislative Assistant, Sen. Bob Kerrey (1998-2000); Senior Budget Committee Analyst (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) |
| AMY JENSEN | Special Assistant to the President for Legislative Affairs (2003-2005); Assistant to the Speaker for Policy (1999-2001) |
Medical/Disease Research/Clinical Labs MED
FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. Finalize PAMA reform of Medicare clinical lab payments.
Foreign entity interest: Ownership and therefore indirect interest in issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE New | — |
| AMY JENSEN | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.